Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza virus delta NS1 vaccine

Next Previous
Drug Profile

Influenza virus delta NS1 vaccine

Alternative Names: deltaFLU LAIV; deltaFLU quadrivalent LAIV; FluVacc; FluVacc - DNS1; Fluvacc delta NS1; FLUVACCdelNS1; FluVaccΔNS1; GHB01L1; GHB04L1; GHB11L1; GHB16L2; H5N1 influenza virus vaccine; Influenza A virus vaccine H1N1; Intranasal H5N1 vaccine - Avir Green Hills Biotechnology; Pandemic avian flu vaccine - Avir Green Hills Biotechnology; Seasonal influenza vaccine deltaFLU; Seasonal influenza virus vaccine Green Hills - Biotechnology

Latest Information Update: 03 Sep 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Green Hills Biotechnology
  • Developer Vivaldi Biosciences
  • Class Antivirals; Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Influenza virus infections

Most Recent Events

  • 03 Sep 2021 Vivaldi Biosciences plans a phase II trial for Influenza virus infection (Vivaldi Biosciences pipeline, September 2021)
  • 12 Oct 2018 Influenza virus delta NS1 vaccine is still in phase II trials for Influenza virus infections in Austria (Vivaldi Biosciences product development, October 2018)
  • 04 Apr 2018 Pharmacodynamics data from a preclinical study in Influenza virus infections released by Vivaldi Biosciences

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top